CELLCEPT
Generic: MYCOPHENOLATE MOFETIL
GenentechManufacturer
ORALRoute
MYCOPHENOLATE MOFETILActive Substance
1995-05-03Original Approval
CELLCEPT is FDA application NDA050722, sponsored by ROCHE PALO. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
19,600 reports
2
DRUG INEFFECTIVE
11,331 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
7,310 reports
4
DIARRHOEA
6,997 reports
5
PYREXIA
5,715 reports
6
PNEUMONIA
5,347 reports
7
CYTOMEGALOVIRUS INFECTION
4,935 reports
8
FATIGUE
4,621 reports
9
NAUSEA
4,579 reports
10
CONDITION AGGRAVATED
4,526 reports